Monoclonal antibodies in the treatment of multiple sclerosis: from clinical research to practical application

Por N. Yu. Lashch
Publicado em 2020-07-01

Use of monoclonal antibodies in patients with multiple sclerosis in the practice of a neurologist

Por N. Yu. Lashch
Publicado em 2020-03-01

Relevance of first-line drugs for treatment of multiple sclerosis in present-day conditions

Por N. Yu. Lashch
Publicado em 2020-12-01

Multiple sclerosis-related fatigue and possibilities of its correction

Por N. Yu. Lashch, A. N. Boiko
Publicado em 2016-03-01

Glatiramer acetate 40 mg/ml: A review of the results of GALA and GLACIER clinical studies

Por N. Yu. Lashch, A. N. Boiko
Publicado em 2016-07-01

New drugs for anti-B-cell therapy of multiple sclerosis

Por A. N. Boyko, N. Yu. Lashch, M. E. Guseva
Publicado em 2018-04-01

Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis

Por O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko
Publicado em 2019-03-01